Expression of Caveolin-1 in Rat Urinary Bladder with Cyclophosphamide-Induced Cystitis
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: The purposes of this study were to investigate the effect of cyclophosphamide (CYP)-induced inflammatory cystitis on caveolin 1 in rat urinary bladder and to determine the role of these molecules in the bladder dysfunction that occurs in inflammatory change in rat urinary bladder. Methods: Female Sprague-Dawley rats were divided into control (n=30) and experimental (n=30) groups. Cystitis in experimental group was induced by intraperitoneal injection of CYP (200 mg/kg). The control group underwent an intraperitoneal saline injection. After 3 days, urodynamic studies were done to measure the contraction interval and contraction pressure. The expression and cellular localization of caveolin 1 were determined by Western blot and immunofluorescent study in rat urinary bladder. Results: In cystometrograms, the contraction interval (minute) was significantly increased in the CYP-induced cystitis rats (15.8±1.5) than in the control group (6.3±0.5) (P<0.05). Conversely, the average contraction pressure (mmHg) was significantly higher in the CYP-induced cystitis rats (15.6±1.7) than in the control group (11.3±0.5) (P<0.05). Caveolin 1 was expressed in the capillaries, arteriols and venules. The protein expression of caveolin 1 was significantly decreased in the CYP-induced cystitis rats (P<0.05). Conclusions: Inflammatory change of urinary bladder maybe causes a significant change in the expression of caveolin 1. These findings suggest that caveolin 1 might have a functional role in the bladder dysfunction related with cystitis in rat urinary bladder.
Abstract
Purpose: The purposes of this study were to investigate the effect of cyclophosphamide (CYP)-induced inflammatory cystitis on caveolin 1 in rat urinary bladder and to determine the role of these molecules in the bladder dysfunction that occurs in inflammatory change in rat urinary bladder. Methods: Female Sprague-Dawley rats were divided into control (n=30) and experimental (n=30) groups. Cystitis in experimental group was induced by intraperitoneal injection of CYP (200 mg/kg). The control group underwent an intraperitoneal saline injection. After 3 days, urodynamic studies were done to measure the contraction interval and contraction pressure. The expression and cellular localization of caveolin 1 were determined by Western blot and immunofluorescent study in rat urinary bladder. Results: In cystometrograms, the contraction interval (minute) was significantly increased in the CYP-induced cystitis rats (15.8±1.5) than in the control group (6.3±0.5) (P<0.05). Conversely, the average contraction pressure (mmHg) was significantly higher in the CYP-induced cystitis rats (15.6±1.7) than in the control group (11.3±0.5) (P<0.05). Caveolin 1 was expressed in the capillaries, arteriols and venules. The protein expression of caveolin 1 was significantly decreased in the CYP-induced cystitis rats (P<0.05). Conclusions: Inflammatory change of urinary bladder maybe causes a significant change in the expression of caveolin 1. These findings suggest that caveolin 1 might have a functional role in the bladder dysfunction related with cystitis in rat urinary bladder.
참고문헌 (16)
- de Groat WC, "The urothelium in overactive bladder: passive bystander or active participant?", Urology, 64(6 Suppl 1), pp.7~11 (2004)
- Smart EJ, "A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane", J Biol Chem, 271, pp.29427~29435 (1996)
- Souto RP, "Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling", J Biol Chem, 278, pp.18321~18329 (2003)
- Lai HH, "Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder", Neurochem Int, 45, pp.1185~1193 (2004)
- Lai HH, "Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder", Urology, 69, pp.407~411 (2007)
- Kim SO, "Effects of Estrogens on the Expression of Caveolin-1 in the Urinary Bladders of Female Rats", International Neurourology Journal, 15(1), pp.13~18 (2011), 대한배뇨장애요실금학회
- chronic cyclophosphamide treatment, "J Physiol Pharmacol", 2010, 477~482
- Wantuch C, "Pharmacological validation of a model of cystitis pain in the mouse", Neurosci Lett, 421, pp.250~252 (2007)
- Bjorling DE, "Models of inflammation of the lower urinary tract", Neurourol Urodyn, 30, pp.673~682 (2011)
- Yoshimura N., "Lower urinary tract symptoms (LUTS) and bladder afferent activity", Neurourol Urodyn, 26(6 Suppl), pp.908~913 (2007)
- Palade GE, "An electron microscope study of the mitochondrial structure", J Histochem Cytochem, 1, pp.188~211 (1953)
- Cohen AW, "Role of caveolae and caveolins in health and disease", Physiol Rev, 84, pp.1341~1379 (2004)
- Li S, "Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases", J Biol Chem, 271, pp.29182~29190 (1996)
- Anderson RG, "The caveolae membrane system", Annu Rev Biochem, 67, pp.199~225 (1998)
- Polyak E, "Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy", J Urol, 182, pp.2497~2503 (2009)
- Cristofaro V, "Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions", Neurourol Urodyn, 26, pp.71~80 (2007)